NASDAQ:REGN   Regeneron Pharmaceuticals, Inc.
This seems as a low risk entry here at 50 days, should rebound if the market continues higher after the previous last week pullback
The market was showing a reversal for most of Friday. Looking for a continuation on Monday.
IBD rating of 98
RS rating 94
Long @ 610.37

Keep it simple: price action and volume
免责声明

这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在使用条款阅读更多信息。